Exit

Have you ever asked yourself …

-          What is best-in-class performance in terms of non-compliance cost (e.g. CAPA, scraping)?
-          How does my supply chain quality compare with that of my market peer group?
-          To which degree are we GDP-compliant and does this reflect our ambition regarding transport performance?

To help you answer these questions and to give you a broader perspective regarding the compliance of your transportation channel, we have developed this survey, which will provide you with a better understanding of your market position. This questionnaire will take approximately 15 minutes to complete. In appreciation of your participation, you will be offered the results of this survey either in paper form or as a digital presentation. We guarantee that all data provided will be anonymised and that only you will see the positioning of your company.
Timing of the study
We kindly request that you submit the answers to this survey by 01st March 2022.
We plan to start issuing and communicating the survey’s results – at first exclusively to participating companies – from 31st March 2022.

Contacts
If you have any further questions or requests, please call or send an email to:
Mr. John Eskaros – Product Manager, Mytigate: John.Eskaros@mytigate.com – T: +4917626972758
Mr. Marcel Müller – Platform Head Operations Pharma & Life Sciences, PWC: mueller.marcel@pwc.com – T: +4915115245109
For further information about Mytigate or PwC, please visit www.mytigate.com and www.pwc.com




Mytigate is a standardised, integrated, preventive supply chain risk management software. It was created by and for the pharma industry, hand in hand with their forwarders and supply-chain partners, with the aim of being the digital hub for the pharma supply chain and a partner for your quality excellence.
PwC's pharmaceuticals and life sciences practice supports pharmaceutical, biotech, and medical device clients to develop future-focused risk-based business strategies and implement compliance programs and procedures essential to success within worldwide regulatory frameworks.
As part of the cooperation between Mytigate and PwC, our benchmark study will support pharma companies in assessing and grading their supply chain processes, understanding the opportunities of proliferating cost-saving through risk mitigation, and realising the possibilities of continuous performance improvements.

T